Direct evidence for a protective role of ACE2 in stroke includes prevention of cerebral damage and behavioral dysfunction in the endothelin-1 (ET-1)-induced MCAO model by administration of an ACE2 activator Diminazene aceturate. The gene discussed is EDN1; the disease is Stroke.